07:00 , Oct 27, 2016 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Prostate cancer Cell culture studies identified an inhibitor of the AKAP13-RHOA interaction that could help treat prostate cancer. Virtual screening of a compound library and in vitro testing of hits yielded a oxopyrazole-furan analog that...